Sendin et al v. Boehringer Ingelheim Pharmaceuticals, Inc. et al
Bertha Sendin and Manuel Sendin |
Pfizer Inc., GlaxoSmithKline LLC and Boehringer Ingelheim Pharmaceuticals, Inc. |
0:2019cv62815 |
November 12, 2019 |
US District Court for the Southern District of Florida |
Rodolfo A Ruiz |
Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
28 U.S.C. ยง 1332 |
Plaintiff |
Docket Report
This docket was last retrieved on December 11, 2019. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 7 ORDER granting #6 Joint Motion to Stay All Proceedings Pending JPML Determination. The Clerk is instructed to CLOSE this case. Any pending motions are DENIED as moot. See attached document for full details. Signed by Judge Rodolfo A Ruiz on 12/11/2019. (mhn) |
Filing 6 Joint MOTION to Stay All Proceedings Pending JPML Determination by Boehringer Ingelheim Pharmaceuticals, Inc., GlaxoSmithKline LLC, Pfizer Inc.. Attorney Hrishikesh Hari added to party GlaxoSmithKline LLC(pty:dft). Responses due by 12/26/2019 (Attachments: #1 Text of Proposed Order)(Hari, Hrishikesh) |
Filing 5 Courtesy Copy of Notice of Related Cases filed before the United States Judicial Panel on Multidistrict Litigation re: Zantac/Ranitidine NDMA Litigation MDL No. 2924. (Attachments: #1 Schedule of Actions, #2 Certificate of Service)(mc) |
Filing 4 Summons Issued as to Boehringer Ingelheim Pharmaceuticals, Inc., GlaxoSmithKline LLC, Pfizer Inc. (pes) |
Filing 3 NOTICE of Filing Proposed Summons(es) by Bertha Sendin, Manuel Sendin (Attachments: #1 Summon(s) Boehringer Ingelheim Pharmaceuticals, Inc., #2 Summon(s) for Glaxosmithkline, LLC, #3 Summon(s) for Pfizer, Inc.) (Ferraro, James) |
Filing 2 Clerks Notice of Judge Assignment to Judge Rodolfo A Ruiz. Pursuant to 28 USC 636(c), the parties are hereby notified that the U.S. Magistrate Judge Barry S. Seltzer is available to handle any or all proceedings in this case. If agreed, parties should complete and file the Consent form found on our website. It is not necessary to file a document indicating lack of consent. Pro se (NON-PRISONER) litigants may receive Notices of Electronic Filings (NEFS) via email after filing a Consent by Pro Se Litigant (NON-PRISONER) to Receive Notices of Electronic Filing. The consent form is available under the forms section of our website. (amb) |
Filing 1 COMPLAINT for Damages and Demand for Jury Trial against Boehringer Ingelheim Pharmaceuticals, Inc., GlaxoSmithKline LLC, Pfizer Inc.. Filing fees $ 400.00 receipt number 113C-12138952, filed by Manuel Sendin, Bertha Sendin. (Attachments: #1 Civil Cover Sheet)(Ferraro, James) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Florida Southern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.